UNSPSC 85705423: Supplement left toe phalanx with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left toe phalanx with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0QUR47Z

UNSPSC 85705423 Supplement left toe phalanx with autologous tissue substitute, percutaneous endoscopic approach is a Commodity code that does not match the work actually being solicited under it in recent state and local procurement records. The code nominally describes a specific orthopedic surgical procedure, yet the most recent opportunities tagged with this code include comprehensive inmate medical and pharmacy services, pharmacy benefit management administration for county employees, virtual primary and urgent care services, peer support services for mental health workers, and fire department medical direction — none of which involve orthopedic surgery or the procurement of tissue substitutes or surgical equipment for toe phalanx procedures.

The mismatch between the code's nominal scope and actual procurement activity suggests this code shows little relevant recent activity for vendors seeking orthopedic surgical supplies or services. Issuers include Muscogee County Prison (Georgia), Collier County Board of Commissioners (Florida), Monroe County Board of Commissioners (Florida), San Mateo County Health (California), and the Santa Monica Fire Department (California), but these opportunities span healthcare administration, employee benefits management, and occupational health support rather than surgical implants or orthopedic procedure-specific materials. Without solicitations that align to the code's stated surgical scope, the code does not represent a viable business development pathway for firms supplying orthopedic tissue substitutes or percutaneous endoscopic surgical services to state and local buyers.